Teleflex has expanded its Arrow ErgoPack Complete system to include haemodialysis and large bore central venous catheters in the US.

The Pennsylvania-based medical technologies provider announced the update to streamline insertion workflow for clinicians and offer more options as per their specific requirements.

Featuring a range of French sizes, lumens, and lengths, the expanded kit configuration gives clinicians the option of using either Arrowg+ard Blue haemodialysis or large bore lines.

According to the medical technologies provider, the expansion of the Arrow ErgoPack Complete System now consists of several clinician-inspired updates.

One of them is the Arrow GlideWheel Advancer, which offers tactile feedback and finer control. The pack also has a kink-resistant nitinol guidewire.

In addition, the Arrow ErgoPack features a transducer cover to support ultrasound use and pre-filled sterile saline syringes, available for each catheter lumen, Teleflex said.

It also includes an extra ChloraPrep Skin Prep in each kit and the option of 3M Tegaderm CHG I.V. Securement Dressing or 3M Tegaderm I.V. Advanced Securement Dressing with BioPatch Protective Disk.

Teleflex vascular access president and general manager Lisa Kudlacz said: “Max barrier kits like the Arrow ErgoPack Complete System provide clinicians with the necessary components they need for their Acute Haemodialysis and Large Bore insertions.

“The intuitive configuration is designed to optimise their workflow, while also meeting the recommendations of CDC, SHEA, INS, and OSHA guidelines.

“Coupling these benefits along with the protection from Arrowg+ard Blue Catheters helps clinicians fight against central line-associated bloodstream infections, protecting their patients and improving their procedures.”

The combination of CVC insertion components in the Arrow ErgoPack Complete System is packaged in an ergonomic and effective configuration of top-down, left to right, according to the medical technologies provider.

It also helps central line inserters in adhering to recommendations of important third-party independent guidelines for lowering central line-associated bloodstream infections (CLABSI).

Recently, Teleflex received the US Food and Drug Administration (FDA) approval for the expanded use of QuikClot Control+ haemostatic device.